Unlock Insights of ALPCO's Fecal Calprotectin Assay Research
View the full poster and explore our findings in detail.
Download our poster to discover how the ALPCO Fecal Calprotectin Assay enables faster, non-invasive IBD and IBS diagnosis and compares leading calprotectin tests.
| Calprotectin Immunoturbidimetric Assay |
|
|---|---|
|
Calprotectin Reagent Set |
80-CALPHU-IT200 |
|
Calprotectin Calibrator Set |
80-CALPHU-ITCAL |
|
Calprotectin Control Set |
80-CALPHU-ITCON |
See for yourself why labs are switching to ALPCO’s new FDA-cleared Calprotectin Immunoturbidimetric Assay
* One free kit per laboratory. Void where prohibited.
Resources to Advance your discoveries
Immunoassay Solutions for Gastroenterology
Targeted Solutions from Extraction to Results. Offering differentiated tests for a variety of GI needs, ALPCO’s menu focuses on testing for GI disorders such as IBD, IBS, pancreatic insufficiency, and more.
Targeted Solutions for Gastroenterology
ALPCO offers targeted GI solutions suitable for all types of labs. Our offerings range from plate-based to clinical chemistry analyzer-based and automated flash chemiluminescence solutions, all designed to accommodate your lab’s expanding testing needs and capabilities.
Differentiating IBD from IBS with Fecal Calprotectin Testing
In an effort to improve patient care, an increasing number of gastroenterologists are using fecal calprotectin levels as a first step in the diagnosis of IBD versus IBS. ALPCO tests enable clinicians to accurately assess patients via calprotectin and quickly start patients on the right treatment path.
ALPCO's Superior Calprotectin Assay: Maximize Efficiency & Accuracy
Reduce False Positives from 26% to 7%! An increase in clinical specificity, and a decrease in false positives, enables clinicians to better evaluate IBD/IBS patients. Clinicians can schedule follow-up colonoscopies for the patients that need it most and start IBS patients on the right treatment path.